MXRA5 and non-small cell lung carcinoma: Somatic mutations of MXRA5 are observed in patients with non-small cell lung cancer (NSCLC) [22], MXRA5 is also aberrantly expressed in colorectal cancer (CRC) tissues, serving as a critical biomarker for the diagnosis and prevention of CRC [23].